Insider · CIK 0001478733

Damaj Bassam

Reports to the SEC for 3 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001478733

Forms 4 and 5

Insider transactions

28 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-11-16	INNOVUS PHARMACEUTICALS, INC.Restricted Stock UnitA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+2M sh	$0.25	+$500K	7,875,000
2016-01-29	INNOVUS PHARMACEUTICALS, INC.Restricted Stock UnitA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+4M sh	—	—	5,875,000
2015-06-26	INNOVUS PHARMACEUTICALS, INC.A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+50 sh	$0.12	+$5.835	6,852,322
2015-03-31	INNOVUS PHARMACEUTICALS, INC.Restricted Stock UnitA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+4.5M sh	—	—	4,500,000
2014-02-19	INNOVUS PHARMACEUTICALS, INC.C Conversion	Director, CHIEF EXECUTIVE OFFICER	CConversion	+1.19M sh	—	—	1,708,265
2014-02-06	INNOVUS PHARMACEUTICALS, INC.Restricted Stock UnitA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+852K sh	—	—	6,852,272
2013-09-09	INNOVUS PHARMACEUTICALS, INC.G Gift	Director, CHIEF EXECUTIVE OFFICER	GGift	−20K sh	—	—	517,854
2013-06-12	INNOVUS PHARMACEUTICALS, INC.P Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+129K sh	$0.32	+$41.8K	129,393
2013-06-12	INNOVUS PHARMACEUTICALS, INC.P Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+287K sh	$0.32	+$92.8K	5,051,270
2013-02-15	INNOVUS PHARMACEUTICALS, INC.Restricted Stock UnitsA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+6M sh	—	—	6,000,000
2013-02-02	INNOVUS PHARMACEUTICALS, INC.P Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+250K sh	$0.48	+$119K	250,406
2013-02-02	INNOVUS PHARMACEUTICALS, INC.P Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+250K sh	$0.48	+$119K	3,459,877
2012-08-23	SEELOS THERAPEUTICS, INC.O Exercise Out-of-Money	Director, President and CEO	OExercise Out-of-Money	+249K sh	—	—	1,610,987
2012-08-21	SEELOS THERAPEUTICS, INC.P Purchase	Director, President and CEO	PPurchase	+760 sh	$2.77	+$2,105.2	1,611,747
2012-08-20	SEELOS THERAPEUTICS, INC.P Purchase	Director, President and CEO	PPurchase	+1,500 sh	$2.69	+$4,034.25	1,361,985
2012-03-05	SEELOS THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+200K sh	—	—	200,000
2011-06-14	SEELOS THERAPEUTICS, INC.J Other	Director, President and CEO	JOther	+90.2K sh	—	—	535,040
2011-06-14	SEELOS THERAPEUTICS, INC.J Other	Director, President and CEO	JOther	+34.3K sh	—	—	825,445
2011-01-31	SEELOS THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+300K sh	—	—	300,000
2011-01-31	SEELOS THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+80K sh	—	—	908,876
2010-10-07	SEELOS THERAPEUTICS, INC.G Gift	Director, President and CEO	GGift	−47K sh	—	—	828,876
2010-06-21	SEELOS THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+483K sh	$2.52	+$1.22M	875,876
2010-06-21	SEELOS THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+204K sh	$2.52	+$514K	327,100
2010-05-24	SEELOS THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+1.5M sh	—	—	5,887,559
2010-03-15	SEELOS THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+1.26M sh	$0.17	+$211K	1,849,740
2010-03-15	SEELOS THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+2.98M sh	$0.17	+$501K	4,387,559
2010-01-11	SEELOS THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+485K sh	$0.17	+$81.6K	1,406,804
2010-01-11	SEELOS THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+205K sh	$0.17	+$34.4K	593,090

Recent filings

Accepted (ET)
Nov 214
INNOVUS PHARMACEUTICALS, INC.0001415889-16-007485
SEC(opens sec.gov)
Feb 24
INNOVUS PHARMACEUTICALS, INC.0001415889-16-004589
SEC(opens sec.gov)
Jun 294
INNOVUS PHARMACEUTICALS, INC.0001415889-15-002218
SEC(opens sec.gov)
Apr 14
INNOVUS PHARMACEUTICALS, INC.0001415889-15-001202
SEC(opens sec.gov)
Feb 214
INNOVUS PHARMACEUTICALS, INC.0001144204-14-010903
SEC(opens sec.gov)
Feb 104
INNOVUS PHARMACEUTICALS, INC.0001144204-14-007256
SEC(opens sec.gov)
Jun 144
INNOVUS PHARMACEUTICALS, INC.0001181431-13-035106
SEC(opens sec.gov)
Feb 194
Damaj Bassam0001144204-13-010083
SEC(opens sec.gov)
Feb 134/A
Damaj Bassam0001144204-13-008393
SEC(opens sec.gov)
Feb 54
Damaj Bassam0001144204-13-006185
SEC(opens sec.gov)
Aug 234
Damaj Bassam0001144204-12-047886
SEC(opens sec.gov)
Aug 214
Damaj Bassam0001144204-12-047248
SEC(opens sec.gov)
Mar 284
Damaj Bassam0001144204-12-017855
SEC(opens sec.gov)
Mar 74
Damaj Bassam0001144204-12-013622
SEC(opens sec.gov)
Feb 14
Damaj Bassam0001144204-11-005344
SEC(opens sec.gov)

Companies

Address

C/O BIO-QUANT, INC. 6330 NANCY RIDGE DRIVE, SUITE 103

SAN DIEGO, CA, 92121